Beleaguered tycoon Vijaya Mallya resigned as chairman of Bayer CropScience Ltd, the Indian subsidiary of the German pharma major Bayer AG, the company said on Tuesday.
"We regretfully accept the voluntary resignation of Vijay Mallya as our director and chairman with effect from June 30, 2016," Bayer CropScience said in a statement here.
A new chairman will be appointed at its next board meeting, it added.
Thanking Mallya for his valuable service, the pharma arm and its promoter (Bayer AG) said it had grown into a market leader during his tenure since March 2004.
"We are grateful to Mallya for his professionalism, dedication and loyalty," the statement added.
As a global enterprise with core competencies in life sciences fields of health care and agriculture, Bayer's products and services are designed to benefit people and improve their quality of life.
In fiscal 2015, the global firm employed about 117,000 people and had sales of euro 46 billion.
--IANS
fb/vd
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
